• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Can J Respir Ther . Post-traumatic stress among COVID-19 survivors: A descriptive study of hospitalized first-wave survivors

tetano

Editor, Senior Moderator
Can J Respir Ther


. 2023 Jan 20;59:20-25.
doi: 10.29390/cjrt-2022-017. eCollection 2023.
Post-traumatic stress among COVID-19 survivors: A descriptive study of hospitalized first-wave survivors


Gilles Rival[SUP] 1 [/SUP], Sophie Chalbet[SUP] 1 [/SUP], Clarisse Dupont[SUP] 1 [/SUP], Philippe Brun[SUP] 1 [/SUP], Lorraine Letranchant[SUP] 2 [/SUP], Claire Reynaud[SUP] 2 [/SUP], Aurélie Dureault[SUP] 2 [/SUP], Julien Saison[SUP] 2 3 [/SUP], Mathieu Jeannot[SUP] 4 [/SUP], Sophie Barbour[SUP] 1 [/SUP], Michaël Bacconnier[SUP] 5 [/SUP], Valérie Paulus[SUP] 1 3 [/SUP], Hélène Champagne[SUP] 2 [/SUP], Guillaume Buiret[SUP] 3 [/SUP]



Affiliations

Abstract

Introduction: The coronavirus Severe Acute Respiratory Syndrome Coronavirus Type 1 induces a severe respiratory disease, coronavirus disease 2019 (COVID-19). After Severe Acute Respiratory Syndrome Coronavirus Type 1 and Middle East Respiratory Syndrome infection, increased post-traumatic stress disorder (PTSD) rates were described.
Methods: This single-centred, prospective study aimed to evaluate the rates of PTSD in patients who were hospitalized for COVID-19. Inclusion criteria were COVID-19 patients hospitalized in the intensive care unit (ICU) or in a standard unit with at least 2 L/min oxygen. Six months post-hospitalization, subjects were assessed for PTSD using a validated screening tool, the Post-Traumatic Stress Checklist-5 (PCL-5).
Results: A total of 40 patients were included. No demographic differences between the ICU and non-ICU groups were found. The mean PCL-5 score for the population was 8.85±10. The mean PCL-5 score was 6.7±8 in the ICU group and 10.5±11 in the non-ICU group (P=0.27). We screened one patient with a positive PCL-5 score and one with a possible PCL-5 cluster score. Nine patients had a PCL-5 score of up to 15. Seven patients reported no symptoms. Seven patients accepted a psychological follow-up: one for PTSD, three for possible PTSD and three for other psychological problems.
Discussion: The PCL-5 tool can be used by lung physicians during consultations to identify patients for whom follow-up mental health assessment and treatment for PTSD are warranted.
Conclusion: Lung physicians should be aware of the risk of PTSD in patients hospitalized for COVID-19 and ensure appropriate screening and follow-up care.

Keywords: COVID-19; crisis intervention; mental health; post-acute COVID-19 syndrome; post-traumatic; stress disorders.
 
Back
Top Bottom